NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

抗體檢驗市場 - COVID-19影響與全球市場分析:至2027年的預測

Antibody Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product ; Indication ; End-User, and Geography.

出版商 The Insight Partners 商品編碼 983299
出版日期 內容資訊 英文 203 Pages
訂單完成後即時交付
價格
抗體檢驗市場 - COVID-19影響與全球市場分析:至2027年的預測 Antibody Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product ; Indication ; End-User, and Geography.
出版日期: 2020年11月30日內容資訊: 英文 203 Pages
簡介

全球抗體檢驗市場,從2019年的64億1,590萬美元,預計到2027年達到107億4,069萬美元,2020年∼2027年以6.7%的年複合成長率成長。

本報告提供全球抗體檢驗市場相關調查分析,市場形勢,市場動態,各市場區隔的市場分析,各地區的市場分析,競爭情形,主要企業相關的系統性資訊。

目錄

第1章 簡介

第2章 抗體檢驗市場:要點

第3章 調查手法

第4章 抗體檢驗市場:市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 抗體檢驗市場:主要的市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 未來趨勢
  • 影響分析

第6章 抗體檢驗市場:全球分析

  • 全球抗體檢驗市場收益預測與分析
  • 全球抗體檢驗市場:各地區 - 預測與分析
  • 主要企業的市場定位

第7章 抗體檢驗市場分析與預測:各產品

  • 概要
  • 全球抗體檢驗:各產品
  • 套件
  • 化學藥品、試劑
  • 消耗品

第8章 抗體檢驗市場分析:各適應症

  • 概要
  • 抗體檢驗市場收益佔有率:各適應症
  • 感染疾病
  • 內分泌疾病
  • 腫瘤
  • 心血管疾病
  • 妊娠
  • 自體免疫疾病
  • 其他

第9章 抗體檢驗市場:各終端用戶

  • 概要
  • 抗體檢驗市場:各終端用戶
  • 臨床檢驗室
  • 醫院
  • 生物製藥企業
  • 學術研究機關

第10章 抗體檢驗市場分析與預測:各地區分析

  • 北美:抗體檢驗市場
  • 歐洲:抗體檢驗市場
  • 亞太地區:抗體檢驗市場
  • 中東、非洲:抗體檢驗市場
  • 中南美:抗體檢驗市場

第11章 COVID-19大流行對全球抗體檢驗市場的影響

  • 北美:COVID-19大流行的影響評估
  • 歐洲:COVID-19大流行的影響評估
  • 亞太地區:COVID-19大流行的影響評估
  • 其他地區:COVID-19大流行的影響評估

第12章 產業形勢

  • 概要
  • 市場企業的成長策略
  • 有機的發展
  • 無機的發展

第13章 企業簡介

  • THERMO FISHER SCIENTIFIC INC.
  • Abbott
  • BIO-RAD LABORATORIES INC.
  • BD
  • F. HOFFMANN-LA ROCHE LTD.
  • Agilent Technologies, Inc.
  • DiaSorin S.p.A.
  • ZEUS Scientific
  • ABCAM
  • Trinity Biotech

第14章 附錄

目錄
Product Code: TIPRE00016492

The Antibody Testing market was valued at US$ million 6,415.90 in 2019 and is projected to reach US$ 10,740.69 million by 2027; it is expected to grow at a CAGR of 6.7% from 2020 to 2027.

The growth of the Antibody Testing market is mainly attributed to factors such as rising number of covid-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population. However, the market is likely to get impacted by the limitations of antibody screening tests during the forecast period.

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That's how immunity to a virus is built. These tests are also called serology tests.

Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures to be taken. Antibody testing is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade. Till date no definitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run Antibody Testing market will have significant growth prospects as many market players has received emergency use authorization for their newly developed antibody tests. All such developments will add up to the future demand for antibody testing market.

Based on Antibody Testing products, the market is segmented into Kits, Chemical and Reagents, Consumables. In 2019, the kits segment accounted for the highest share of the market. Growth of this segment is attributed to the large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and higher adoption of kits in various research processes. The same segment is likely to register highest CAGR in the global Antibody Testing market during the forecast period.

Global Antibody Testing Market, based on indication, the Antibody Testing market is segmented into Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, Others. The Infectious Diseases segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 8.0% in the market during the forecast period.

Global Antibody Testing Market, based on end user, the Antibody Testing market is segmented into Hospitals, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies. The Diagnostic Laboratories segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 7.4 % in the market during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), Centers For Disease Control And Prevention, American Heart Association, Biomedical Advanced Research and Development Authority, Foundation For Innovative New Diagnostics are some of the major primary and secondary sources referred for preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Antibody Testing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global Antibody Testing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Antibody Testing Market - By Product
    • 1.3.2 Antibody Testing Market - By Indication
    • 1.3.3 Antibody Testing Market - By End User
    • 1.3.4 Global Antibody Testing Market - By Geography

2. Antibody Testing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Antibody Testing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East & Africa - PEST Analysis
    • 4.2.5 South & Central America- PEST Analysis
  • 4.3 Expert Opinions

5. Antibody Testing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Number of COVID-19 Cases Worldwide
    • 5.1.2 Increasing Prevalence of Chronic Diseases
    • 5.1.3 Growing Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Limitations of Antibody Screening Tests
  • 5.3 Market Opportunities
    • 5.3.1 Collaborative & Innovation-Driven Strategies
    • 5.3.2 Growth of Healthcare Sector in Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories
  • 5.5 Impact Analysis

6. Antibody Testing Market - Global Analysis

  • 6.1 Global Antibody Testing Marker Revenue Forecast and Analysis
  • 6.2 Global Antibody Testing Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Antibody Testing Market Analysis and Forecasts to 2027 Product

  • 7.1 Overview
  • 7.2 Global Antibody Testing, by Product, 2019 & 2027 (% Share)
  • 7.3 Kits
    • 7.3.1 Overview
    • 7.3.2 Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.3 Serological Test Kits
      • 7.3.3.1 Overview
      • 7.3.3.2 Serological Test Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.4 Immunoglobulin Kits
      • 7.3.4.1 Overview
      • 7.3.4.2 Immunoglobulin Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.5 Lateral Flow Assay Kits
      • 7.3.5.1 Overview
      • 7.3.5.2 Lateral Flow Assay Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Chemical and Reagents
    • 7.4.1 Overview
    • 7.4.2 Global Chemical and Reagents Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Consumables
    • 7.5.1 Overview
    • 7.5.2 Global Consumables Market Revenue and Forecast to 2027 (US$ Mn)

8. Antibody Testing Market Analysis - By Indication

  • 8.1 Overview
  • 8.2 Antibody Testing Market Revenue Share, by Indication (2019 and 2027)
  • 8.3 Infectious Diseases
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Endocrine Diseases
    • 8.4.1 Overview
    • 8.4.2 Endocrine Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Oncology
    • 8.5.1 Overview
    • 8.5.2 Oncology: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Cardiovascular Diseases
    • 8.6.1 Overview
    • 8.6.2 Cardiovascular Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Pregnancy
    • 8.7.1 Overview
    • 8.7.2 Pregnancy: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.8 Autoimmune Diseases
    • 8.8.1 Overview
    • 8.8.2 Autoimmune Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.9 Other Diseases
    • 8.9.1 Overview
    • 8.9.2 Other Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)

9. Antibody Testing Market - By End-User

  • 9.1 Overview
  • 9.2 Antibody Testing Market, by End-User, 2019 and 2027 (%)
  • 9.3 Diagnostic Laboratories
    • 9.3.1 Overview
    • 9.3.2 Global Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Hospitals
    • 9.4.1 Overview
    • 9.4.2 Global Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Biopharmaceutical Companies
    • 9.5.1 Overview
    • 9.5.2 Biopharmaceutical Companies: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Academic Research Institutes
    • 9.6.1 Overview
    • 9.6.2 Academic Research Institutes: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)

10. Antibody Testing Market Analysis and Forecasts To 2027 Geographical Analysis

  • 10.1 North America: Antibody Testing Market
    • 10.1.1 Overview
    • 10.1.2 North America: Antibody Testing Market, - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.1 North America: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Antibody Testing Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 US: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.5 US: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Canada: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.5 Canada: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 Mexico: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.5 Mexico: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.2 Europe: Antibody Testing Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Antibody Testing Market, by Product - Revenue and Forecast to 2027(USD Million)
      • 10.2.3.1 Europe: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Europe: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.2.5 Europe: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Europe: Antibody Testing Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.2.7.2.1 Germany: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 Germany: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.4 Germany: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 UK: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.2.8.2.1 UK: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 UK: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.4 UK: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 France: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.2.9.2.1 France: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 France: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.4 France: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 Spain: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.2.10.2.1 Spain: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 Spain: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.4 Spain: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Italy: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.2.11.2.1 Italy: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Italy: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.4 Italy: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.12 Rest of Europe: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.1 Rest of Europe: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.2 Rest of Europe: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.2.12.2.1 Rest of Europe: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.3 Rest of Europe: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.4 Rest of Europe: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Asia Pacific: Antibody Testing Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia-Pacific: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.3.1 Asia-Pacific: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Asia-Pacific: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.3.5 Asia-Pacific: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Asia Pacific: Antibody Testing Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 China: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.3.7.3.1 China: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.4 China: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.5 China: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 Japan: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.3.8.2.1 Japan: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 Japan: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.4 Japan: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 India: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.3.9.2.1 India: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 India: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.4 India: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.10 South Korea: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.3.10.2.1 South Korea: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.3 South Korea: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.4 South Korea: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.11 Australia: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.3.11.2.1 Australia: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.4 Australia: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.12 Rest of Asia Pacific: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.1 Rest of Asia Pacific: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.2 Rest of Asia Pacific: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 10.3.12.2.1 Rest of Asia Pacific: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.3 Rest of Asia Pacific: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.4 Rest of Asia Pacific: Antibody Testing Market, by End-User - Revenue and Forecast to 2027 (USD Million)
  • 10.4 Middle East & Africa: Antibody Testing Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
      • 10.4.3.1 Middle East & Africa: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East & Africa Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East & Africa Antibody Testing Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East & Africa Antibody Testing Market, by Country, 2019 & 2027 (%)
    • 10.4.7 Saudi Arabia: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 Saudi Arabia: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 Saudi Arabia Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.5 Saudi Arabia Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 UAE: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 UAE: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 UAE: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.5 UAE: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.3 South Africa: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.4 South Africa Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.5 South Africa Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.10 Rest of Middle East and Africa: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.1 Rest of Middle East and Africa: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.2 Rest of Middle East & Africa Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.3 Rest of Middle East & Africa: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.4 Rest of Middle East & Africa: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.5 Rest of Middle East & Africa: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Antibody Testing Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
      • 10.5.3.1 South and Central America: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Antibody Testing Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.4 Brazil: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.5 Brazil: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Argentina: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.4 Argentina: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.5 Argentina: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.5.9 Rest of South and Central America: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.1 Rest of South and Central America: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.2 Rest of South and Central America: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.3 Rest of South and Central America: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.4 Rest of South and Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.5 Rest of South and Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Antibody Testing Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 THERMO FISHER SCIENTIFIC INC.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Abbott
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 BIO-RAD LABORATORIES INC.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 BD
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 F. HOFFMANN-LA ROCHE LTD.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Agilent Technologies, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 DiaSorin S.p.A.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 ZEUS Scientific
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 ABCAM
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Trinity Biotech
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Total Number of Persons Aged 60 Years or Above - by Region, 2017 & 2050
  • Table 2. North America: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 9. US: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Canada: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Mexico: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Mexico: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Europe: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 19. Europe: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Europe: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Europe: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 22. Prevalence of diabetes and related risk factors in Germany:
  • Table 23. Germany: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 24. Germany: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Germany: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Germany: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 27. Cancer Statistics for the UK
  • Table 28. UK: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 29. UK: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 30. UK: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 31. UK: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 32. France: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 33. France: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 34. France: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 35. France: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 36. Spain: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 37. Spain: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Spain: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Spain: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 40. Italy: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 41. Italy: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Italy: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Italy: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 44. Rest of Europe: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 45. Rest of Europe: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Rest of Europe: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Rest of Europe: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 48. Asia-Pacific: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 49. Asia-Pacific: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Asia-Pacific: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Asia-Pacific: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 52. Incidence rate of cancer in 2019 in China
  • Table 53. China: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 54. China: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 55. China: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 56. China: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 57. Japan: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 58. Japan: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 59. Japan: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 60. Japan: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 61. India: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 62. India: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. India: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 64. India: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 65. South Korea: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 66. South Korea: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 67. South Korea: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 68. South Korea: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 69. Australia: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 70. Australia: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Australia: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Australia: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 73. Rest of Asia Pacific: Antibody Testing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 74. Rest of Asia Pacific: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 75. Rest of Asia Pacific: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Rest of Asia Pacific: Antibody Testing Market, by End-User- Revenue and Forecast to 2027 (USD Million)
  • Table 77. Middle East & Africa Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Middle East & Africa: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 79. Middle East & Africa Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 80. Middle East & Africa Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 81. Saudi Arabia Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 82. Saudi Arabia: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 83. Saudi Arabia Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 84. Saudi Arabia Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 85. UAE: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 86. UAE: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 87. UAE: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 88. UAE: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 89. South Africa Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 90. South Africa: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 91. South Africa Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million
  • Table 92. South Africa Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 93. Rest of Middle East & Africa: Antibody Testing Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 94. Rest of Middle East & Africa: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 95. Rest of Middle East & Africa: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 96. Rest of Middle East & Africa: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 97. South and Central America: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
  • Table 98. South and Central America: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 99. South and Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
  • Table 100. South and Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 101. Brazil: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
  • Table 102. Brazil: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 103. Brazil: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
  • Table 104. Brazil: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 105. Argentina: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
  • Table 106. Argentina: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 107. Argentina: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
  • Table 108. Argentina: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 109. Rest of South and Central America: Antibody Testing Market, by Products - Revenue and Forecast to 2027 (USD Million)
  • Table 110. Rest of South and Central America: Kits Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 111. Rest of South and Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
  • Table 112. Rest of South and Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 113. Organic Developments Done By Companies
  • Table 114. Inorganic Developments Done By Companies
  • Table 115. Glossary of Terms, Antibody Testing Market

List Of Figures

  • Figure 1. Antibody Testing Market Segmentation
  • Figure 2. Antibody Testing Market - By Geography
  • Figure 3. Antibody Testing Market Overview
  • Figure 4. Kits Product Segment Held Largest Share of Antibody Testing Market
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Antibody Testing Market, by Geography (US$ Million)
  • Figure 7. Global Antibody Testing Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Antibody Testing Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Global Antibody Testing Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Antibody Testing Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Antibody Testing Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Antibody Testing Market
  • Figure 18. Global Antibody Testing, By Product, 2019 & 2027 (% Share)
  • Figure 19. Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Serological Test Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Immunoglobulin Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Lateral Flow Assay Kits: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Global Chemical and Reagents Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 24. Global Consumables Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 25. Antibody Testing Market Revenue Share, by Indication (2019 and 2027)
  • Figure 26. Infectious Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Endocrine Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Most Prevalent Forms of Cancers Globally, 2018
  • Figure 29. Oncology: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Cardiovascular Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Pregnancy: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Autoimmune Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Other Diseases: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. Antibody Testing Market, by End-User, 2019 and 2027 (%)
  • Figure 35. Global Diagnostic Laboratories Market Revenue And Forecast To 2027 (US$ Mn)
  • Figure 36. Global Hospitals Market Revenue And Forecast To 2027 (US$ Mn)
  • Figure 37. Biopharmaceutical Companies: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 38. Academic Research Institutes: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 39. North America: Antibody Testing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 40. North America: Antibody Testing Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 41. North America: Antibody Testing Market, by Country, 2019 & 2027 (%)
  • Figure 42. US: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Canada: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Mexico: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Europe: Antibody Testing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. Europe Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Europe: Antibody Testing Market, by Country, 2019 & 2027 (%)
  • Figure 48. Germany: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. UK: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. France: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Spain: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Italy: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Rest of Europe: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Asia Pacific: Antibody Testing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 55. Asia Pacific Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Asia Pacific: Antibody Testing Market, by Country, 2019 & 2027 (%)
  • Figure 57. China: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. Japan: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. India: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. South Korea: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Australia: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 62. Rest of Asia Pacific: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Middle East & Africa: Antibody Testing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 64. Middle East & Africa Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Middle East & Africa: Antibody Testing Market, by Country, 2019 & 2027 (%)
  • Figure 66. Saudi Arabia: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. UAE: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 68. South Africa: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 69. Rest of Middle East and Africa: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 70. South and Central America: Antibody Testing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 71. South and Central America Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 72. South and Central America: Antibody Testing Market, by Country, 2019 & 2027 (%)
  • Figure 73. Brazil: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 74. Argentina: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 75. Rest of South and Central America: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 76. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 77. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in Rest of the World Market
  • Figure 80. Growth Strategies Done by the Companies in the Market, (%)